Indrayani Biotech (BOM:526445) Other Stockholders Equity: ₹0 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:526445 Indrayani Biotech Ltd BOM:526445
51 GF Score
Price ₹8.23
GF Value ₹41.48
Valuation Possible Value Trap
! 7 Warning Signs
View Full Analysis

What is Indrayani Biotech Other Stockholders Equity?

Indrayani Biotech BOM:526445 51 Other Stockholders Equity is ₹0 Mil as of Dec. 2025. GuruFocus rates BOM:526445 with a GF Score™ of 51/100 and a GF Value™ of ₹41.48 (Possible Value Trap). The stock has 7 warning signs investors should review.

Indrayani Biotech's Other Stockholders Equity for the quarter that ended in Dec. 2025 was ₹0 Mil.

Indrayani Biotech's quarterly Other Stockholders Equity increased from Jun. 2025 (₹0 Mil) to Sep. 2025 (₹303 Mil) but then declined from Sep. 2025 (₹303 Mil) to Dec. 2025 (₹0 Mil).

Indrayani Biotech's annual Other Stockholders Equity increased from Mar. 2023 (₹18 Mil) to Mar. 2024 (₹42 Mil) but then declined from Mar. 2024 (₹42 Mil) to Mar. 2025 (₹35 Mil).

Indrayani Biotech Other Stockholders Equity Historical Data

* Premium members only.

The historical data trend for Indrayani Biotech's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Indrayani Biotech Other Stockholders Equity Chart

Indrayani Biotech Annual Data
Trend Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25
Other Stockholders Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.05 0.09 18.24 41.77 35.47

Indrayani Biotech Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
Other Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 35.47 0.00 302.79 0.00
BOM:526445
51GF Score
Indrayani Biotech Ltd BOM:526445
Other Stockholders Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Indrayani Biotech Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity

What does a Other Stockholders Equity of ₹0 Mil mean?
Indrayani Biotech (BOM:526445) has a Other Stockholders Equity of ₹0 Mil as of Dec. 2025. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on Indrayani Biotech and its competitors.
Is Indrayani Biotech's Other Stockholders Equity too high?
Indrayani Biotech's current Other Stockholders Equity is ₹0 Mil. Overall, Indrayani Biotech has a GF Score™ of 51/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Indrayani Biotech's Other Stockholders Equity compare to CTAS and CPRT?
Indrayani Biotech's Other Stockholders Equity of ₹0 Mil can be compared against companies in the Business Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Stockholders Equity for a Business Services company?
A good Other Stockholders Equity depends on the Business Services industry context. However, Other Stockholders Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Stockholders Equity mean?
A high Other Stockholders Equity can signal that a stock is expensive relative to its fundamentals. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on Indrayani Biotech and its competitors. Indrayani Biotech's current Other Stockholders Equity is ₹0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Indrayani Biotech stock overvalued right now?
Based on GuruFocus' analysis, Indrayani Biotech (BOM:526445) is currently considered Possible Value Trap. The stock's GF Value™ is ₹41.48, compared to a current price of ₹8.23 — trading 80.2% below its estimated fair value. The current Other Stockholders Equity is ₹0 Mil. Indrayani Biotech's overall GF Score™ is 51/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Stockholders Equity calculated?
Other Stockholders Equity is calculated from a company's financial statements. For Indrayani Biotech (BOM:526445), the current Other Stockholders Equity is ₹0 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Indrayani Biotech (BOM:526445) Overvalued in 2026?

Based on GuruFocus' analysis, Indrayani Biotech stock appears to be undervalued. The current stock price of ₹8.23 is trading 80.2% below its estimated GF Value™ of ₹41.48. GuruFocus considers Indrayani Biotech to be Possible Value Trap.

Key valuation signals for BOM:526445:

  • Other Stockholders Equity: ₹0 Mil
  • GF Value™: ₹41.48 vs. price of ₹8.23 (80.2% below fair value)
  • GF Score™: 51/100 with 7 warning signs

No single metric tells the full story. See the BOM:526445 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Indrayani Biotech Business Description

Address Module No. 33, Block 1, 3rd Floor, SIDCO Electronic Complex, Thiru-vi-ka Industrial Estate, Guindy, Chennai, TN, IND, 600032
Indrayani Biotech Ltd operates in the Tri-segment i.e. Foods & Hospitality, Engineering and Healthcare divisions. The company generates its revenue from the sale of food, beverages, and other items; the Sale of Engineering products & Others. The majority of its revenue is generated from the sale of food, beverages, and other items.
51GF Score

Get the complete analysis for BOM:526445

Other Stockholders Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹8.23
Price
₹41.48
GF Value